Publications

5891 Results

Prognostic value of regulatory T-cells, lymphoma associated macrophages and Mum-11 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study [PMC2875547; PMID19875761]

Authors
JW Sweetenham;B Goldman;M LeBlanc;JR Cook;RR Tubbs;OW Press;DG Maloney;RI Fisher;LM Rimsza;ED Hsi
Journal / Conference
Annals of Oncology 21(6):1196-1202;
Year
2010
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8809, S9800, S9911

A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): a Southwest Oncology Group study (S0331)

Authors
WE Samlowski;J Moon;RJ Tuthill;MC Heinrich;SA Merl;RC DeConti;JA Thompson;MT Witter;LE Flaherty;VK Sondak
Journal / Conference
American Journal of Clinical Oncology, Oct; 33(5):495-499;
Year
2010
Research Committee(s)
Melanoma
PMID
PMID20019577
PMC
PMC2978644
Study Number(s)
S0331

Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients [PMC2834472; PMID20124181]

Authors
M. Van Glabbeke;J. Verweij;J-Y. Blay;M. Debiec-Rychter;G.D. Demetri;M.C. Heinrich;E.C. Borden;B.G. Redman;C.D. Blanke;C. Rankin;J.J. Crowley;P. Casali;M. von Mehren;C. Fletcher;J. Fletcher;K. Owzar;J. Zalcberg;J. Simes;V. Bramwell-Wesley
Journal / Conference
Journal of Clinical Oncology 28(7):1247-1253;
Year
2010
Research Committee(s)
Sarcoma
Study Number(s)
S0033

Multiplexed assessment of the Southwest Oncology Group directed intergroup breast cancer trial S9313 by AQUA show both high and low levels of HER2 are associated with poor outcome [PMC2843456; PMID20150438]

Authors
M Harigopal;W Barlow;G Tedeschi;P Porter;I Yeh;C Haskell;R Livingston;G Hortobagyi;G Sledge;C Shapiro;J Ingle;D Rimm;DF Hayes
Journal / Conference
American Journal of Pathology 176(4):1639-1647;
Year
2010
Research Committee(s)
Breast
Study Number(s)
SWOG-9313

A phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small cell lung cancer (NSCLC): an NCCTG and SWOG study, N0426 [PMC2815996; PMID19841321]

Authors
AA Adjei;SJ Mandrekar;GK Dy;JR Molina;A Adjei;GR Gandara;KL Ziegler;PJ Stella;KM Rowland;SE Schild;RG Zinner
Journal / Conference
Journal of Clinical Oncology 28(4):614-619
Year
2010
Research Committee(s)
Lung
Study Number(s)
N0426

Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with cyclosporine, in older patients with previously untreated acute myeloid leukemia (AML) [PMID 19821823; PMC2967366]

Authors
TR Chauncey;H Gundacker;M Shadman;AF List;SR Dakhil;HP Erba;ML Slovak;I-M Chen;CL Willman;K Kopecky;FR Appelbaum
Journal / Conference
British Journal of Haematology 148(1):48-58;
Year
2010
Research Committee(s)
Leukemia
Study Number(s)
S0112, S0301

Expression of p21 protein predicts clinical outcome in DLBCL patients treated with R-CHOP: a prospective ECOG and SWOG correlative study of E4494 [PMC2865202; PMID20371683]

Authors
JN Winter;V Aurora;V Variakojis;B Nelson;M Krajewska;L Zhang;T Habermann;RI Fisher;WR Macon;M Chhanabhai;RE Felgar;ED Hsi;LJ Medeiros;JK Weick;EA Weller;A Melnick;JC Reed;SJ Horning;RD Gascoyne
Journal / Conference
Clinical Cancer Research 16(8):2435-2442;
Year
2010
Research Committee(s)
Lymphoma
Study Number(s)
E4494

Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205. [PMID20606093; PMC2917315]

Authors
PA Philip;JK Benedetti;CL Corless;R Wong;E O'Reilly;PJ Flynn;KM Rowland;JN Atkins;BC Mirtsching;SE Rivkin;AA Khorana;B Goldman;CM Fenoglio-Preiser;JL Abbruzzese;CD Blanke
Journal / Conference
Journal of Clinical Oncology 28(22):3605-3610;
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
S0205

Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012) [PMID19851858; PMC3024910]

Authors
ML Slovak;V Bell;D Lew;KS Albain;GK Elllis;RB Livingston;S Martino;EA Perez;GN Hortobagyi;D Sher;W Stock
Journal / Conference
Breast Cancer Research and Treatment 119(2):391-398
Year
2010
Research Committee(s)
Breast
Study Number(s)
S0012

Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III randomized, open-label study comparing gemcitabine plus cetuximab (IMC-225) versus gemcitabine as first-line therapy of patients with advanced pancreas cancer [PMID20606094; PMC2917316]

Authors
CM Moinpour;N Vaught;B Goldman;M Redman;PA Philip;B Millwood;S Lippman;TE Seay;P Flynn;E O'Reilly;KM Rowland;R Wong;J Benedetti;CD Blanke
Journal / Conference
Journal of Clinical Oncology 28(22):3611-3616
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
S0205